Comments on Medicare Program, CY 2021 Address Multiple Concerns

Oct 5, 2020

Friday, ASRA submitted comments to the Centers for Medicare and Medicaid Services regarding a number of aspects of two proposed rules.

In a letter to Administrator Seema Verma, MPH, ASRA presented feedback on several issues regarding CMS-1723-P:

  1. Mitigate the steep cut to the conversion factor due to multiple changes in evaluation and management (E/M) payment and related policies;
  2. Translate the increase E/M values to global surgery codes;
  3. Continue coverage and increased payment for telephone only E/M services;
  4. Work with Congress to eliminate originating site requirements and geographic restrictions;
  5. Withdraw policies that inappropriately expand scope of practice of non-physician practitioners;
  6. Work with federal agency partners to remove barriers to electronic prescribing of controlled substances (EPCS);
  7. Delay implementation of MIPS Value Pathways (MVPs); and,
  8. Retain the current (Year 4) MIPS Quality and Cost performance category weights and performance thresholds, in light of COVID-19 pandemic efforts.

In a letter to Administrator Verma regarding CMS-1736-P, ASRA addressed issues regarding:

  1. Delay elimination of the Inpatient Only List (IPO) List, and
  2. Eliminate all prior authorizations under the OPPS, but especially for implanted spinal neurostimulators.

ASRA Advocacy News

Return to all news